{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:17:30Z","timestamp":1790842650408,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome\/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the limited efficacy of chemotherapy and to the patient\u2019s age, which is usually not eligible for transplantation. Comprehensive analysis of CMML pathophysiology and the development of therapeutic agents have been limited partly due to the lack of cell lines in CMML and the limited developments of mouse models. After successfully establishing patient\u2019s derived disease-specific induced pluripotent stem cells (iPSCs) derived from a patient with CMML, we utilized these CMML-iPSCs to achieve hematopoietic re-differentiation <jats:italic>in vitro<\/jats:italic>, created a humanized CMML mouse model via teratomas, and developed a drug-testing system. The clinical characteristics of CMML were recapitulated following hematopoietic re-differentiation <jats:italic>in vitro<\/jats:italic> and a humanized CMML mouse model <jats:italic>in vivo<\/jats:italic>. The drug-testing system using CMML-iPSCs identified a MEK inhibitor, a Ras inhibitor, and liposomal clodronate as potential drugs for treating CMML. Clodronate is a drug commonly used as a bisphosphonate for osteoporosis. In this study, the liposomalization of clodronate enhanced its effectiveness in these assays, suggesting that this variation of clodronate may be adopted as a repositioned drug for CMML therapy.<\/jats:p>","DOI":"10.1038\/s41598-018-34193-1","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:38:14Z","timestamp":1540204694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate"],"prefix":"10.1038","volume":"8","author":[{"given":"Kazuki","family":"Taoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-9902","authenticated-orcid":false,"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Aixinjueluo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiki","family":"Kumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-0217","authenticated-orcid":false,"given":"Makoto","family":"Otsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsutoshi","family":"Nakahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Nakauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"34193_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872, https:\/\/doi.org\/10.1016\/j.cell.2007.11.019 (2007).","journal-title":"Cell"},{"key":"34193_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.027","volume":"369","author":"A Yilmazer","year":"2015","unstructured":"Yilmazer, A., de Lazaro, I. & Taheri, H. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling? Cancer Lett 369, 1\u20138, https:\/\/doi.org\/10.1016\/j.canlet.2015.06.027 (2015).","journal-title":"Cancer Lett"},{"key":"34193_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.exphem.2015.06.006","volume":"43","author":"S Arai","year":"2015","unstructured":"Arai, S., Miyauchi, M. & Kurokawa, M. Modeling of hematologic malignancies by iPS technology. Exp Hematol 43, 654\u2013660, https:\/\/doi.org\/10.1016\/j.exphem.2015.06.006 (2015).","journal-title":"Exp Hematol"},{"key":"34193_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nbt.3178","volume":"33","author":"AG Kotini","year":"2015","unstructured":"Kotini, A. G. et al. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells. Nat Biotechnol 33, 646\u2013655, https:\/\/doi.org\/10.1038\/nbt.3178 (2015).","journal-title":"Nat Biotechnol"},{"key":"34193_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","volume":"20","author":"AG Kotini","year":"2017","unstructured":"Kotini, A. G. et al. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell 20, 315\u2013328.e317, https:\/\/doi.org\/10.1016\/j.stem.2017.01.009 (2017).","journal-title":"Cell Stem Cell"},{"key":"34193_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2016.11.018","volume":"20","author":"MP Chao","year":"2017","unstructured":"Chao, M. P. et al. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell Stem Cell 20, 329\u2013344.e327, https:\/\/doi.org\/10.1016\/j.stem.2016.11.018 (2017).","journal-title":"Cell Stem Cell"},{"key":"34193_CR7","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/jco.2012.47.3314","volume":"31","author":"R Itzykson","year":"2013","unstructured":"Itzykson, R. et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol 31, 2428\u20132436, https:\/\/doi.org\/10.1200\/jco.2012.47.3314 (2013).","journal-title":"J Clin Oncol"},{"key":"34193_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405, https:\/\/doi.org\/10.1182\/blood-2016-03-643544 (2016).","journal-title":"Blood"},{"key":"34193_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/ajh.25104","volume":"93","author":"MM Patnaik","year":"2018","unstructured":"Patnaik, M. M. & Tefferi, A. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management. Am J Hematol 93, 824\u2013840, https:\/\/doi.org\/10.1002\/ajh.25104 (2018).","journal-title":"Am J Hematol"},{"key":"34193_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc.2017.40","volume":"17","author":"MWN Deininger","year":"2017","unstructured":"Deininger, M. W. N., Tyner, J. W. & Solary, E. Turning the tide in myelodysplastic\/myeloproliferative neoplasms. Nat Rev Cancer 17, 425\u2013440, https:\/\/doi.org\/10.1038\/nrc.2017.40 (2017).","journal-title":"Nat Rev Cancer"},{"key":"34193_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458\u2013466, https:\/\/doi.org\/10.1002\/stem.1293 (2013).","journal-title":"Stem Cells"},{"key":"34193_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.stem.2009.08.001","volume":"5","author":"Y Yoshida","year":"2009","unstructured":"Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T. & Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5, 237\u2013241, https:\/\/doi.org\/10.1016\/j.stem.2009.08.001 (2009).","journal-title":"Cell Stem Cell"},{"key":"34193_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/stem.402","volume":"28","author":"P Mali","year":"2010","unstructured":"Mali, P. et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28, 713\u2013720, https:\/\/doi.org\/10.1002\/stem.402 (2010).","journal-title":"Stem Cells"},{"key":"34193_CR14","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1182\/blood-2007-10-117622","volume":"111","author":"N Takayama","year":"2008","unstructured":"Takayama, N. et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111, 5298\u20135306, https:\/\/doi.org\/10.1182\/blood-2007-10-117622 (2008).","journal-title":"Blood"},{"key":"34193_CR15","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1182\/blood-2012-10-460170","volume":"121","author":"E Padron","year":"2013","unstructured":"Padron, E. et al. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood 121, 5068\u20135077, https:\/\/doi.org\/10.1182\/blood-2012-10-460170 (2013).","journal-title":"Blood"},{"key":"34193_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood-2012-06-434407","volume":"121","author":"G Amabile","year":"2013","unstructured":"Amabile, G. et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121, 1255\u20131264, https:\/\/doi.org\/10.1182\/blood-2012-06-434407 (2013).","journal-title":"Blood"},{"key":"34193_CR17","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/mt.2013.71","volume":"21","author":"N Suzuki","year":"2013","unstructured":"Suzuki, N. et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 21, 1424\u20131431, https:\/\/doi.org\/10.1038\/mt.2013.71 (2013).","journal-title":"Mol Ther"},{"key":"34193_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","volume":"95","author":"SM Zeisberger","year":"2006","unstructured":"Zeisberger, S. M. et al. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95, 272\u2013281, https:\/\/doi.org\/10.1038\/sj.bjc.6603240 (2006).","journal-title":"Br J Cancer"},{"key":"34193_CR19","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1182\/blood-2013-01-478412","volume":"121","author":"S Gandre-Babbe","year":"2013","unstructured":"Gandre-Babbe, S. et al. Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood 121, 4925\u20134929, https:\/\/doi.org\/10.1182\/blood-2013-01-478412 (2013).","journal-title":"Blood"},{"key":"34193_CR20","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1182\/blood-2013-05-500090","volume":"121","author":"RJ Chan","year":"2013","unstructured":"Chan, R. J. & Yoder, M. C. JMML patient-derived iPSCs induce new hypotheses. Blood 121, 4815\u20134817, https:\/\/doi.org\/10.1182\/blood-2013-05-500090 (2013).","journal-title":"Blood"},{"key":"34193_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood-2017-01-763219","volume":"130","author":"A Yoshimi","year":"2017","unstructured":"Yoshimi, A. et al. Robust patient-derived xenografts of MDS\/MPN overlap syndromes capture the unique characteristics of CMML and JMML. Blood 130, 397\u2013407, https:\/\/doi.org\/10.1182\/blood-2017-01-763219 (2017).","journal-title":"Blood"},{"key":"34193_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4493","volume":"24","author":"M Seiler","year":"2018","unstructured":"Seiler, M. et al. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nat Med 24, 497\u2013504, https:\/\/doi.org\/10.1038\/nm.4493 (2018).","journal-title":"Nat Med"},{"key":"34193_CR23","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/bloodadvances.2017004903","volume":"1","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines. Blood Adv 1, 972\u2013979, https:\/\/doi.org\/10.1182\/bloodadvances.2017004903 (2017).","journal-title":"Blood Adv"},{"key":"34193_CR24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ki.2012.207","volume":"82","author":"DA Ferenbach","year":"2012","unstructured":"Ferenbach, D. A. et al. Macrophage\/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia\/reperfusion injury in mice. Kidney Int 82, 928\u2013933, https:\/\/doi.org\/10.1038\/ki.2012.207 (2012).","journal-title":"Kidney Int"},{"issue":"4","key":"34193_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s13346-017-0404-5","volume":"8","author":"Etty Grad","year":"2017","unstructured":"Grad, E. et al. The role of monocyte subpopulations in vascular injury following partial and transient depletion. Drug Deliv Transl Res, https:\/\/doi.org\/10.1007\/s13346-017-0404-5 (2017).","journal-title":"Drug Delivery and Translational Research"},{"key":"34193_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fcimb.2017.00408","volume":"7","author":"JA Cunha","year":"2017","unstructured":"Cunha, J. A. et al. Increased Plasmodium falciparum Parasitemia in Non-splenectomized Saimiri sciureus Monkeys Treated with Clodronate Liposomes. Front Cell Infect Microbiol 7, 408, https:\/\/doi.org\/10.3389\/fcimb.2017.00408 (2017).","journal-title":"Front Cell Infect Microbiol"},{"key":"34193_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nbt.1530","volume":"27","author":"J Deng","year":"2009","unstructured":"Deng, J. et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 27, 353\u2013360, https:\/\/doi.org\/10.1038\/nbt.1530 (2009).","journal-title":"Nat Biotechnol"},{"key":"34193_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4161\/epi.27160","volume":"9","author":"K Hannula-Jouppi","year":"2014","unstructured":"Hannula-Jouppi, K. et al. Differentially methylated regions in maternal and paternal uniparental disomy for chromosome 7. Epigenetics 9, 351\u2013365, https:\/\/doi.org\/10.4161\/epi.27160 (2014).","journal-title":"Epigenetics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34193-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:52:40Z","timestamp":1671619960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34193"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34193-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15855"}}